469 related articles for article (PubMed ID: 35395857)
1. The role of TBK1 in cancer pathogenesis and anticancer immunity.
Runde AP; Mack R; S J PB; Zhang J
J Exp Clin Cancer Res; 2022 Apr; 41(1):135. PubMed ID: 35395857
[TBL] [Abstract][Full Text] [Related]
2. The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.
Möller M; Wasel J; Schmetzer J; Weiß U; Meissner M; Schiffmann S; Weigert A; Möser CV; Niederberger E
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630674
[TBL] [Abstract][Full Text] [Related]
3. A review on the role of TANK-binding kinase 1 signaling in cancer.
Alam M; Hasan GM; Hassan MI
Int J Biol Macromol; 2021 Jul; 183():2364-2375. PubMed ID: 34111484
[TBL] [Abstract][Full Text] [Related]
4. Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes.
Zhang H; Chen L; Cai SH; Cheng H
Leuk Res; 2016 Jul; 46():37-44. PubMed ID: 27123832
[TBL] [Abstract][Full Text] [Related]
5. Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis.
Hammaker D; Boyle DL; Firestein GS
Rheumatology (Oxford); 2012 Apr; 51(4):610-8. PubMed ID: 21613249
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1.
Abe T; Barber GN
J Virol; 2014 May; 88(10):5328-41. PubMed ID: 24600004
[TBL] [Abstract][Full Text] [Related]
7. TBK1 (TANK-binding kinase 1)-mediated regulation of autophagy in health and disease.
Herhaus L
Matrix Biol; 2021 Jun; 100-101():84-98. PubMed ID: 33454423
[TBL] [Abstract][Full Text] [Related]
8. Evaluating TBK1 as a therapeutic target in cancers with activated IRF3.
Muvaffak A; Pan Q; Yan H; Fernandez R; Lim J; Dolinski B; Nguyen TT; Strack P; Wu S; Chung R; Zhang W; Hulton C; Ripley S; Hirsch H; Nagashima K; Wong KK; Jánne PA; Seidel-Dugan C; Zawel L; Kirschmeier PT; Middleton RE; Morris EJ; Wang Y
Mol Cancer Res; 2014 Jul; 12(7):1055-66. PubMed ID: 24752990
[TBL] [Abstract][Full Text] [Related]
9. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
Zhou Z; Qi J; Lim CW; Kim JW; Kim B
Toxicology; 2020 Nov; 444():152579. PubMed ID: 32905826
[TBL] [Abstract][Full Text] [Related]
10. TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes.
Möser CV; Stephan H; Altenrath K; Kynast KL; Russe OQ; Olbrich K; Geisslinger G; Niederberger E
J Neuroinflammation; 2015 May; 12():100. PubMed ID: 25997745
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug development: Challenges and opportunities.
Alam M; Ansari MM; Noor S; Mohammad T; Hasan GM; Kazim SN; Hassan MI
Int J Biol Macromol; 2022 May; 207():1022-1037. PubMed ID: 35358582
[TBL] [Abstract][Full Text] [Related]
12. The IKK-related kinases: from innate immunity to oncogenesis.
Clément JF; Meloche S; Servant MJ
Cell Res; 2008 Sep; 18(9):889-99. PubMed ID: 19160540
[TBL] [Abstract][Full Text] [Related]
13. Role of TBK1 Inhibition in Targeted Therapy of Cancer.
Yang X; Liu Z
Mini Rev Med Chem; 2024 Jan; ():. PubMed ID: 38314681
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles for the non-canonical IKKs in cancer.
Shen RR; Hahn WC
Oncogene; 2011 Feb; 30(6):631-41. PubMed ID: 21042276
[TBL] [Abstract][Full Text] [Related]
15. Novel cross-talk within the IKK family controls innate immunity.
Clark K; Peggie M; Plater L; Sorcek RJ; Young ER; Madwed JB; Hough J; McIver EG; Cohen P
Biochem J; 2011 Feb; 434(1):93-104. PubMed ID: 21138416
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
Pomerantz JL; Baltimore D
EMBO J; 1999 Dec; 18(23):6694-704. PubMed ID: 10581243
[TBL] [Abstract][Full Text] [Related]
18. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
Lee Y; Song B; Park C; Kwon KS
PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467
[TBL] [Abstract][Full Text] [Related]
19. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TANK-binding kinase1 attenuates the astrocyte-mediated neuroinflammatory response through YAP signaling after spinal cord injury.
Zhang W; Jia M; Lian J; Lu S; Zhou J; Fan Z; Zhu Z; He Y; Huang C; Zhu M; Wang J; Wang Y; Huang Z; Teng H
CNS Neurosci Ther; 2023 Aug; 29(8):2206-2222. PubMed ID: 37032635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
